Cargando…
Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells
A major unmet need in the cystic fibrosis (CF) therapeutic landscape is the lack of effective treatments for nonsense CFTR mutations, which affect approximately 10% of CF patients. Correction of nonsense CFTR mutations via genomic editing represents a promising therapeutic approach. In this study, w...
Autores principales: | Li, Chao, Liu, Zhong, Anderson, Justin, Liu, Zhongyu, Tang, Liping, Li, Yao, Peng, Ning, Chen, Jianguo, Liu, Xueming, Fu, Lianwu, Townes, Tim M., Rowe, Steven M., Bedwell, David M., Guimbellot, Jennifer, Zhao, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686454/ https://www.ncbi.nlm.nih.gov/pubmed/38019847 http://dx.doi.org/10.1371/journal.pone.0295009 |
Ejemplares similares
-
Robust Stimulation of W1282X-CFTR Channel Activity by a Combination of Allosteric Modulators
por: Wang, Wei, et al.
Publicado: (2016) -
The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing superfunctional protein that can be further enhanced by CFTR modulators
por: Chen, Jianguo, et al.
Publicado: (2023) -
Homology Requirements for Efficient, Footprintless Gene Editing at the CFTR Locus in Human iPSCs with Helper-dependent Adenoviral Vectors
por: Palmer, Donna J, et al.
Publicado: (2016) -
Clinical Presentation of the c.3844T>C (p.Trp1282Arg, W1282R) Variant in Russian Cystic Fibrosis Patients
por: Petrova, Nika V., et al.
Publicado: (2020) -
Microhomology-assisted scarless genome editing in human iPSCs
por: Kim, Shin-Il, et al.
Publicado: (2018)